University College London Hospitals NHS Foundation Trust
In research, University College London Hospitals NHS Foundation Trust stands highest in Medicine (#801 of 10,443 worldwide), Health Sciences (#1,017 of 11,982 worldwide) and Surgery (#555 of 1,816 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Rheumatology and Pulmonary and Respiratory Medicine — Hematology is 10.1× its share of world research.
- World rank, 2022–2025
- #3,449 of 28,054 · #4,662 all time
- Rank in United Kingdom
- #135 of 1,094
- Research works
- 2.3k ▲ 77% vs 2013–17
- Citations
- 50k 22.4 per fractional work
- Top-10% rate
- 20.0% record average 16.5%
- Open access
- 54% world 28%
What is University College London Hospitals NHS Foundation Trust known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #801 of 10,443 | 19.8% | 555 | #1048 | |
| Health SciencesDomain | #1,017 of 11,982 | 19.6% | 601 | #1240 | |
| SurgerySubfield | #555 of 1,816 | 19.2% | 83 | #1082 | |
| Life SciencesDomain | #2,504 of 7,800 | 21.1% | 79 | #3476 | |
| Pulmonary and Respiratory MedicineSubfield | #678 of 1,144 | 16.7% | 69 | #918 |
Each strip is that field’s whole ranked pool, with the notch where University College London Hospitals NHS Foundation Trust sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,048 #801
- Health Sciences#1,240 #1,017
- Surgery#1,082 #555
- Life Sciences#3,476 #2,504
- Pulmonary and Respiratory Medicine#918 #678
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does University College London Hospitals NHS Foundation Trust specialise in?
Where its research is concentrated relative to its size: Hematology takes 10.1× the share of its output that it takes of world research.
- HematologySubfield · 22.9 works10×
- RheumatologySubfield · 21.4 works6.3×
- Pulmonary and Respiratory MedicineSubfield · 69.1 works6.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Immunology and Microbiology 2.2×
- Health Professions 1.9×
- Neuroscience 1.2×
- Nursing 1.2×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Dentistry 0.9×
- Psychology 0.7×
- Veterinary 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Physics and Astronomy 0.4×
- Economics, Econometrics and Finance 0.3×
- Mathematics 0.2×
- Business, Management and Accounting 0.2×
- Decision Sciences 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Energy 0.1×
- Chemistry 0.1×
- Arts and Humanities 0.1×
- Agricultural and Biological Sciences 0.0×
- Materials Science 0.0×
- Earth and Planetary Sciences 0.0×
Which keywords describe research at University College London Hospitals NHS Foundation Trust?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Immunotherapy, Prognostic Factors, Radiotherapy, Diagnosis, Treatment and Clinical Practice Guidelines.
- Tumor Staging
- Staging System
- MRI Imaging
- Neoadjuvant Therapy
- Human Papillomavirus
- Rituximab
- Survival Analysis
- Genetic Variants
- Rehabilitation
- Health-related Quality of Life
- Prostate Cancer
- Guidelines
- Complications
- Genetic Mutations
- Clinical Practice Guidelines
- Risk Factors
- Inflammation
- Quality of Life
- Treatment
- Chemotherapy
- Epidemiology
- Immunotherapy
- Diagnosis
- Prognostic Factors
- Radiotherapy
- Clinical Trials
- Management
- Surgical Management
- Biomarkers
- Mortality
- Clinical Guidelines
- Surgery
- Prognosis
- Screening
- Adjuvant Therapy
- Lymphoma
- Radiation Therapy
- Molecular Characterization
- Minimal Residual Disease
- Survival Rates
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology90▲ 3.0×123 topics
- Chemotherapy39▲ 7.4×25 topics
- Immunotherapy34▲ 6.4×19 topics
- Treatment32▲ 3.5×46 topics
- Diagnosis30▲ 4.4×41 topics
- Quality of Life30▲ 2.8×45 topics
- Prognostic Factors28▲ 8.4×14 topics
- Inflammation27▲ 1.75×62 topics
- Radiotherapy24▲ 8.3×13 topics
- Risk Factors24▲ 2.9×28 topics
- Clinical Trials23▲ 4.5×15 topics
- Clinical Practice Guidelines22▲ 5.5×14 topics
- Management21▲ 3.6×30 topics
- Genetic Mutations20▲ 6.2×23 topics
- Surgical Management20▲ 6.5×20 topics
- Complications18▲ 4.9×17 topics
- Biomarkers18▲ 3.5×14 topics
- Guidelines18▲ 5.2×13 topics
- Mortality18▲ 4.1×12 topics
- Prostate Cancer15▲ 16×4 topics
- Clinical Guidelines14▲ 6.7×9 topics
- Health-related Quality of Life14▲ 8.0×5 topics
- Surgery13▲ 4.9×11 topics
- Rehabilitation13▲ 4.3×13 topics
- Prognosis12▲ 5.1×9 topics
- Genetic Variants12▲ 9.3×7 topics
- Screening12▲ 17×3 topics
- Survival Analysis12▲ 5.9×6 topics
- Adjuvant Therapy12▲ 13×2 topics
- Rituximab12▲ 11×4 topics
- Lymphoma12▲ 9.7×4 topics
- Human Papillomavirus12▲ 12×3 topics
- Radiation Therapy11▲ 12×6 topics
- Neoadjuvant Therapy11▲ 6.2×5 topics
- Molecular Characterization10▲ 7.5×5 topics
- MRI Imaging10▲ 15×4 topics
- Minimal Residual Disease10▲ 18×2 topics
- Staging System9▲ 20×2 topics
- Survival Rates9▲ 13×2 topics
- Tumor Staging9▲ 11×2 topics
Which research topics does University College London Hospitals NHS Foundation Trust publish most on?
By volume in 2022–2025: Prostate Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Genital Health and Disease and Esophageal and GI Pathology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 8 works
- 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 8 works
- 3 Genital Health and Disease Surgery 7 works
- 4 Esophageal and GI Pathology Surgery 7 works
- 5 Multiple Myeloma Research and Treatments Hematology 7 works
- 6 CAR-T cell therapy research Oncology 6 works
- 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 6 works
- 8 Chronic Lymphocytic Leukemia Research Genetics 6 works
- 9 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 6 works
- 10 Advanced Radiotherapy Techniques Radiation 6 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has University College London Hospitals NHS Foundation Trust's research output changed?
Output in 2018–2022 was 77% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.